
Alfaxalone - Wikipedia
Alfaxalone, also known as alphaxalone or alphaxolone and sold under the brand name Alfaxan, is a neuroactive steroid and general anesthetic which is used currently in veterinary practice as …
Alfaxalone | C21H32O3 | CID 104845 - PubChem
Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for …
Alfaxalone: An Old Drug in a New Formulation - Today's …
Alfaxalone (3α-hydroxy-5α-pregnane-11,20-dione) is a synthetic neuroactive steroid used to induce and maintain general anesthesia.
Alfaxalone: Uses, Interactions, Mechanism of Action | DrugBank …
2016年2月25日 · Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is …
Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone …
Alfaxalone has been reformulated for human use as Phaxan, an aqueous solution of 10 mg/mL of alfaxalone and 13% betadex. This study assessed the pharmacokinetic (PK) and …
Alfaxalone - an overview | ScienceDirect Topics
Alfaxalone is a neurologically active steroid compound that induces general anesthesia. Alfaxalone exerts its action by binding to GABA receptors on the neuronal cell surface, …
Structural basis of neurosteroid anesthetic action on GABA
2018年9月28日 · Alphaxalone (5α-pregnan-3α-ol-11,20 dione) is a potent neurosteroid anesthetic. The anxiolytic, anticonvulsant, analgesic, and sedative-hypnotic effects of alphaxalone have …
Alfaxalone anaesthesia increases brain derived neurotrophic factor ...
2022年12月24日 · Alfaxalone is a fast acting intravenous anaesthetic with high therapeutic index. It is an analogue of the naturally-occurring neurosteroid allopregnanolone responsible for …
ALFAXALONE - 药物在线
FDA全球物质注册数据库(FDA Global Substance Registration System)
Interaction of alfaxalone with the neuronal and the skeletal muscle ...
Alfaxalone preferentially blocked slow inactivated channels and therefore could provide membrane-stabilizing effects in ischemic/hypoxic tissues where slow inactivation is regarded …